Barrett’s Esophagus Patients Have Same Survival Rates as General Population

	Tweet

New Mayo Clinic research has found that survival rates of patients with Barrett’s esophagus, which can be a precursor for esophageal cancer, are no different than the survival rates for the general population. These findings were presented today at the 2009 American College of Gastroenterology (ACG) Annual Meeting in San Diego.

Barrett’s esophagus is most often diagnosed in people who have long-term gastroesophageal reflux disease (GERD)—a chronic regurgitation of acid from the stomach into the lower esophagus. A diagnosis of Barrett’s esophagus can be concerning because it increases the risk of developing esophageal cancer.

“Patients who are diagnosed with Barrett’s esophagus often fear they will develop esophageal cancer and not survive long,” says Ganapathy Prasad, M.D., gastroenterologist, Mayo Clinic and lead author on the study. “Our research examined the survival rates of Barrett’s esophagus patients from Olmsted County, Minn., over the past three decades, compared to a control group of patients. We wanted to study overall survival, predictors of survival and ultimate cause of death in patients.”

In this study of 366 patients, the average patient age was 63 years, with 72 percent men and 18 percent women. All patients with a diagnosis of Barrett’s esophagus from 1977–2006 were identified using the Rochester Epidemiology Project resources in Olmsted County and confirmed via review of medical records. Only patients from Olmsted County were selected to reduce referral and selection bias.

Survival data and cause of death was ascertained from medical records of the 366 patients. Overall survival at 10 years after diagnosis was 68 percent. Causes of death included 28 percent from cardiovascular disease, 7 percent from dementia and 7 percent from esophageal cancer. The overall survival of this group was comparable to that of a control sample from the 2000 U.S. census.

“Our population-based study found that Barrett’s esophagus patients are at no greater risk of dying than the rest of the population,” says Dr. Prasad. “Patients who receive this diagnosis should seek proper treatment and care, but should also know that their odds of dying from esophageal cancer are low.”

The Mayo Clinic Barrett’s Esophagus Unit offers a multidisciplinary approach to evaluate early symptoms, devise a surveillance schedule and perform all tests and medical and surgical treatments.

Mayo Clinic’s Division of Gastroenterology and Hepatology has been ranked No. 1 in the U.S. News & World Report Honor Roll of Top Hospitals since the rankings began 20 years ago.

About Mayo Clinic
Mayo Clinic is the first and largest integrated, not-for-profit group practice in the world. Doctors from every medical specialty work together to care for patients, joined by common systems and a philosophy of “the needs of the patient come first.” More than 3,300 physicians, scientists and researchers and 46,000 allied health staff work at Mayo Clinic, which has sites in Rochester, Minn., Jacksonville, Fla., and Scottsdale/Phoenix, Ariz. Collectively, the three locations treat more than half a million people each year. To obtain the latest news releases from Mayo Clinic, go to http://www.mayoclinic.org/news. For information about research and education, visit http://www.mayo.edu. MayoClinic.com (http://www.mayoclinic.com) is available as a resource for your health stories.

Source:  Mayo Clinic

RELATED STORIES:
How to treat gastroesophageal adenocarcinom patients?   What Are the Key Statistics About Cancer of the Esophagus?   Gene Variations Alter Risk of Esophageal Cancer   Black raspberries slow cancer by altering hundreds of genes   Wine may cut risk of esophagus pre-cancer   What causes cancer of the esophagus?   Red meat linked to esophageal, stomach cancer risks   Aspirin Significantly Reduces Esophageal-Cancer Risk In People With Most- Aggressive Form Of Barrett   Esophageal Cancer Overview of Prevention   Thriving After Cancer: Care Plans Help Map the Road to Wellness   Alcohol type linked to Barrett’s esophagus risk   Minimally-Invasive Treatment Found Effective for Esophageal Cancer   How is cancer of the esophagus diagnosed?   Married oesophageal cancer patients fare worse in some quality of life aspects than single patients   Researchers use sugar to halt esophageal cancer in its tracks   Daily drinking may raise risk of several cancers   Is increased Slug expression associated with the progression to esophageal cancer?   Barrett’s patients who smoke are twice as likely to develop esophageal cancer   What are the side effects of treatment for cancer of the esophagus?   Esophageal cancer risk higher in medically treated GERD patients with fewest symptoms   Triple therapy prolongs life in esophageal cancer   A biotherapy strategy for esophageal cancer in the future

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]